Abiopharma

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site

LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3

Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference

Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results

Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference

Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform

Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group

Fortive Reports Third Quarter 2025 Results

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference